Research and experimental development on natural sciences and engineering
ANELSEN AS
Revenue 2024
NOK 2.6m
Operating profit
NOK −5.5m
Equity
NOK 39.1m
Incorporated
2005
Share capital
NOK 100,000
Roles
Daglig lederOle Egil Kvaleberg
Revisor
Styrets lederOle Egil Kvaleberg
VaramedlemSonja Irene Landa
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| OLE EGIL KVALEBERG | 100.0% | 1000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| JUALAKO AS | Active | 100.0% | 5000.000000 |
| ASTRUM GROUP AS | Active | 5.3% | 288602.000000 |
| PREF 2018 AS | Active | 3.5% | 627875.000000 |
| GLUCOSET AS | Active | 3.4% | 4758.000000 |
| GLUCOSET AS | Active | 3.2% | 4406.000000 |
| MARITIME OPPORTUNITIES AS | Active | 2.9% | 29032.000000 |
| NC SPECIAL SITUATIONS AS | Active | 2.6% | 26189.000000 |
| PREF 2020 AS | Active | 2.3% | 504000.000000 |
| NC SPECIAL SITUATIONS 2 AS | Active | 1.6% | 20000.000000 |
| PREF 2018 AS | Active | 1.3% | 228311.000000 |
| DNB PE DIRECT I (IS) AS | Active | 1.2% | 1000.000000 |
| DNB PRIVATE EQUITY IV (IS) AS | Active | 0.8% | 10000.000000 |
| WELLMEND AS | Active | 0.3% | 1816.000000 |
| APIM THERAPEUTICS AS | Active | 0.1% | 2975.000000 |
| NORDIC TECHNOLOGY GROUP AS | Active | 0.1% | 181176.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.